Emily Murrell
Affiliations: | 2014-2019 | Chemistry | The University of Western Ontario (Canada) |
Google:
"Emily Murrell"Mean distance: (not calculated yet)
Parents
Sign in to add mentorLeonard G Luyt | grad student | 2014-2019 | The University of Western Ontario (Canada) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
von Spreckelsen N, Fadzen CM, Hartrampf N, et al. (2021) Targeting glioblastoma using a novel peptide specific to a deglycosylated isoform of brevican. Advanced Therapeutics. 4 |
Murrell E, Luyt LG. (2020) Incorporation of Fluorine into an OBOC Peptide Library by Copper-Free Click Chemistry toward the Discovery of PET Imaging Agents. Acs Combinatorial Science |
Turnbull WL, Murrell E, Bulcan-Gnirss M, et al. (2019) A study of Tc/Re-tricarbonyl complexes of 4-amino-1,8-naphthalimides. Dalton Transactions (Cambridge, England : 2003) |
von Spreckelsen N, Ghotmi Y, Fadzen C, et al. (2019) DDIS-36. BTP-7, A NOVEL PEPTIDE FOR THERAPEUTIC TARGETING OF MALIGNANT BRAIN TUMORS Neuro-Oncology. 21: vi71-vi71 |
Turnbull WL, Yu L, Murrell E, et al. (2018) A dual modality Tc/Re(i)-labelled T140 analogue for imaging of CXCR4 expression. Organic & Biomolecular Chemistry |
Murrell E, Kovacs MS, Luyt LG. (2018) A Compact and Synthetically Accessible Fluorine-18 Labelled Cyclooctyne Prosthetic Group for Labelling of Biomolecules by Copper-free Click Chemistry. Chemmedchem |
Cho C, Ghotmi Y, Fadzan C, et al. (2018) DDIS-26. BTP-7, A NOVEL PEPTIDE FOR THERAPEUTIC TARGETING OF MALIGNANT BRAIN TUMORS Neuro-Oncology. 20: vi74-vi74 |
Cho C, Ghotmi Y, Fazden C, et al. (2017) DDIS-19. NOVEL PEPTIDE HOMING TO GLIOMA-SPECIFIC ISOFORM OF BREVICAN SELECTIVELY TARGETS MALIGNANT BRAIN TUMORS Neuro-Oncology. 19: vi62-vi63 |
Simpson EJ, Gobbo P, Bononi FC, et al. (2017) Bombesin-functionalized water-soluble gold nanoparticles for targeting prostate cancer Journal of Interdisciplinary Nanomedicine. 2: 174-187 |